Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Airway Responsiveness Methodologies and Efficacy of Budesonide/Formoterol in Asthmatics
NCT02574975Phase 4Unknown
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Apr 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide and formoterol in asthma (5 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Positive rate of bronchial provocation test at 3 months. Status: unknown.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02574975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574975.